Good morning, and welcome to another working week. Elizabeth Cooney here, filling in for the vacationing Ed Silverman from STAT’s global HQ in Boston, where the coffee is never flavored. We welcome your comments, suggestions, and especially your tips.

Flu vaccine may have to be airlifted into Britain to prevent a winter crisis in the event of a no-deal Brexit, according to the largest producer of the shots, the Times of London notes. Hugo Fry, U.K. chief of the French drugs giant Sanofi (SNY), said the extreme measure may be needed because of the threat of crucial supplies being stuck in long lines at the British border. Sanofi, which distributes the vaccine by trucks from Normandy, has decided to increase its drug stockpile in case Britain fails to secure a trade deal before leaving the E.U. in March. But vaccine for winter 2019-20 wouldn’t be added to those reserves because it normally arrives in the U.K. in the preceding August.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy